BioSpace News Archive

Cortexyme, Inc. (Nasdaq: CRTX) today announced that its work to pioneer upstream therapeutic approaches to improve the lives of patients diagnosed with Alzheimer’s and other degenerative diseases will be the subject of three research abstracts at the Alzheimer’s Association International Conference ® 2020 (AAIC ® ). The largest international meeting dedicated to advancing dementia science, AAIC will be held

GT Biopharma, Inc. announced today it had completed a private offering resulting in aggregate gross proceeds of approximately $5.6 million.

Vericel Corporation (NASDAQ:VCEL), a leader in advanced therapies for the sports medicine and severe burn care markets, today announced the following webcast and conference call to discuss its second-quarter 2020 financial results and business highlights. What: Vericel Corporation Second-Quarter 2020 Earnings Call When: Wednesday, August 5, 2020 at 8:30am (EDT) Where: http://investors.vcel.com/events-present

Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE), a biopharmaceutical company focused on the development and commercialization of novel products for rare and ultra-rare diseases, today announced that Dojolvi™ (triheptanoin) is now commercially available. The U.S. Food and Drug Administration (FDA) approved Dojolvi on June 30, 2020 as a source of calories and fatty acids for the treatment of pediatric and adult patients with molecularly confirmed l

Company launches Time to Evolve campaign to equip surgeons and hospital systems with tools and resources to support their evolution to less invasive surgical techniques

Startup to Continue Research with University of Illinois Urbana-Champaign into How Video Chat Technology Can Help Aging Adults

GRMC ranked among the top 5% percent of U.S. hospitals for patient experience in 2020 by HealthGrades.

Eikonoklastes Therapeutics, a preclinical stage biopharmaceutical company developing next-generation tissue factor (TF) immunotherapies for triple-negative breast cancer (TNBC) and several other diseases with unmet clinical need, today announced closing of an oversubscribed seed financing. Working with The Ohio State University Corporate Engagement Office and seed investor CincyTech, the company was formed to advance technolo

Cullinan Oncology, LLC today announced the launch of Cullinan Amber, a company focused on developing a next generation immuno-oncology platform to enhance the therapeutic window of immune-stimulatory cytokine combinations for the treatment of cancer. Cullinan Amber has acquired an exclusive license from the Massachusetts Institute of Technology for technology based on the seminal work of K. Dane Wittrup, the C. P. Dubbs

Endometriosis is a common, chronic and often misdiagnosed disorder that affects 6-10 percent of women. Today, researchers at the Feinstein Institutes for Medical Research published new data in the journal Frontiers in Reproductive Health which helps validate the hypothesis that menstrua